Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Contact

Biomarkers for the clinical evaluation of cognitive impairment

  • Category: Published research
  • Product: NeuroQuant
  • Disease: Neurodementias, Traumatic brain injury

Biomarkers for the clinical evaluation of the cognitively impaired elderly, amyloid is not enough

Recently published in the journal Imaging in Medicine (June, 2012), Linda K. McEvoy and James B. Brewer argue that while incorporating biomarkers for assessing Alzheimer’s disease risk, including volumetric MRI done with NeuroQuant®, can help in patient prognosis, tests for amyloid, if used in isolation, have potential for harm, as amyloid tests are clinically useful only when evidence suggests progressive cognitive decline or neurodegeneration. (Imaging in Medicine, June 2012, Vol. 4, No. 3 , Pages 343-357).

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports
  • 6 mins

06/27/2025

Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports

Accurate, objective data is important in the effort to standardize reporting on vascular lesions and their associated pathologies.

Cortechs.ai | Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game
  • 3 mins

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

Cortechs.ai | Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region
  • 2 mins

06/11/2025

Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region

We’re excited to announce our new partnership with RMS Medical Devices to our advanced neuroimaging and prostate imaging solutions to the Benelux region

Cortechs.ai | Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology
  • 3 mins

06/04/2025

Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology

Press Release: Delivering Clinically Validated AI Solutions for Enhanced Imaging Precision and Workflow Efficiency

Cortechs.ai | Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 
  • 2 mins

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology

Cortechs.ai | Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging
  • 2 mins

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.

,

View our insights
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top